Zymeworks BC Inc
ZYME
Market Cap$611.83M
Close$
$-8.73
207.7% downside
Current Fair Value
207.7% downsideOvervalued by 207.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $611.83 Million |
|---|---|
| Enterprise Value | $370.11 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-4.06 |
| Beta | 1.07 |
| Outstanding Shares | 70,568,222 |
| Avg 30 Day Volume | 502,611 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.58 |
|---|---|
| PEG | 60.05 |
| Price to Sales | - |
| Price to Book Ratio | 2.7 |
| Enterprise Value to Revenue | 11.7 |
| Enterprise Value to EBIT | -1.54 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani